Clinical trial for Psychosis
Official title Effects of Action-Based Cognitive Remediation on Substance Misuse in Early Phase Psychosis
ClinicalTrials.gov ID: NCT07056894
What this study is testing
- What it's testing
- The study wants to see whether Action‑Based Cognitive Remediation (ABCR) can reduce substance misuse in people with early phase psychosis.
- Who it's for
- It is looking for people who have early psychosis and also use alcohol or cannabis.
- What's involved
- Participants will attend 16 therapy sessions, held twice a week for about two months, to work on thinking skills and everyday functioning.
- Time commitment
- The program lasts about two months, with 16 bi‑weekly visits and related assessments.
- Time commitment: about 6 months
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 16 to 30
You may be able to join if
- This study will enroll individuals 16-30 years of age from the Early Intervention Services for Psychosis programs in Nova Scotia and the Psychosis...
- Diagnosed with a primary psychotic disorder (e.g. schizophrenia, schizoaffective disorder, and unspecified schizophrenia spectrum disorder)
- Less than 5 years of psychotic illness
- Has problematic alcohol and/or cannabis use (score of 8 or higher on the World Health Organization Alcohol Use Disorders Identification Test...
You likely can't join if
- Current stimulant use disorder
The study team makes the final eligibility decision.
Where it is enrolling
- St. John's, Newfoundland and Labrador, Canada
- Halifax, Nova Scotia, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The study runs about 6 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 16 years to 30 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at St. John's, Newfoundland and Labrador, Canada; Halifax, Nova Scotia, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.